Response to: Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.

Autor: Kawaguchi, Yuji, Hajika, Yuriko, Ashida, Narumi, Masumoto, Koji, Sawa, Jun, Hamazaki, Kenji, Kumeda, Yasuro
Zdroj: Advances in Therapy; Jan2023, Vol. 40 Issue 1, p381-382, 2p
Databáze: Complementary Index
Externí odkaz: